Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A five-domain functional framework for integrative physiology: a coherent and operational approach to whole-body function.

Frontiers in physiology·2026

Same author

Countercurrent multiplication revisited: key conceptual updates and framework expansion.

Advances in physiology education·2026

Same author

How should we teach homeostasis? Filling the gaps and envisioning the future.

Frontiers in physiology·2026

Same author

A unified framework for van 't Hoff's law: addressing the complexity of osmotic concentration.

Royal Society open science·2025

Same author

Unravelling tonicity: Causes of confusion and pathways to clarity.

Current research in physiology·2025

Same author

From compliance to moduli: clarifying basic mechanical properties of biological tissues.

Advances in physiology education·2025

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

How useful are stem cells in PD therapy?

Yu Luo¹, Serena Y Kuang, Barry Hoffer

¹National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.

Parkinsonism & Related Disorders

|January 20, 2010

Summary

This summary is machine-generated.

Stem cell therapy offers a promising approach for Parkinson's disease (PD) treatment. Embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells) show potential for replacing damaged dopaminergic neurons, though further research is needed for clinical application.

More Related Videos

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Published on: April 13, 2018

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Related Experiment Videos

Last Updated: Jun 17, 2026

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Electrically Conductive Scaffold to Modulate and Deliver Stem Cells

Published on: April 13, 2018

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Area of Science:

Neuroscience
Regenerative Medicine
Stem Cell Biology

Background:

Parkinson's disease (PD) is a common neurodegenerative disorder affecting dopaminergic neurons, with symptoms appearing late in disease progression.
Current treatments for PD are limited, highlighting the need for novel therapeutic strategies like cell replacement therapy.

Purpose of the Study:

To evaluate the potential of stem cells, including embryonic stem (ES) cells and induced pluripotent stem cells (iPS cells), for treating Parkinson's disease.
To explore the feasibility and challenges associated with using stem cell-derived dopaminergic neurons for cell replacement therapy in PD.

Main Methods:

Review of studies involving transplantation of fetal mesencephalic dopaminergic neurons, undifferentiated ES cells, and predifferentiated ES cells in rodent PD models.
Examination of recent advancements in induced pluripotent stem cells (iPS cells) for PD treatment.

Main Results:

Fetal cell transplants showed some improvement in motor function but faced ethical and logistical limitations.
ES cells demonstrated proliferation and differentiation into dopaminergic neurons in a PD model, with predifferentiation reducing tumor risk.
Initial success reported with iPS cells in a rodent PD model.

Conclusions:

Stem cell-based therapies, particularly using ES and iPS cells, hold significant promise for Parkinson's disease treatment.
Further investigation is required to determine the clinical translatability of iPS cell therapy for human Parkinson's disease patients.